244 related articles for article (PubMed ID: 22885983)
1. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
3. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
4. Contrast agents for MRI.
Shokrollahi H
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
[TBL] [Abstract][Full Text] [Related]
5. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall Europium, Gadolinium, and Dysprosium Oxide Nanoparticles: Polyol Synthesis, Properties, and Biomedical Imaging Applications.
Yue H; Park JY; Chang Y; Lee GH
Mini Rev Med Chem; 2020; 20(17):1767-1780. PubMed ID: 32496986
[TBL] [Abstract][Full Text] [Related]
8. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
10. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
11. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
13. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Field-Optimized Paramagnetic Nanoprobe for
Huo L; Zeng J; Wang Z; Sun X; Guo Y; Cao Z; Zhu S; Tan M; Li M; Chen X; Zhao Z
ACS Nano; 2024 May; 18(19):12453-12467. PubMed ID: 38686995
[TBL] [Abstract][Full Text] [Related]
15. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
16. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
[TBL] [Abstract][Full Text] [Related]
17. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
18. Mixed lanthanide oxide nanoparticles as dual imaging agent in biomedicine.
Xu W; Bony BA; Kim CR; Baeck JS; Chang Y; Bae JE; Chae KS; Kim TJ; Lee GH
Sci Rep; 2013 Nov; 3():3210. PubMed ID: 24220641
[TBL] [Abstract][Full Text] [Related]
19. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
20. Lanthanide-DTPA grafted silica nanoparticles as bimodal-imaging contrast agents.
Pinho SL; Faneca H; Geraldes CF; Delville MH; Carlos LD; Rocha J
Biomaterials; 2012 Jan; 33(3):925-35. PubMed ID: 22035824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
